|
16 Sep 2025 |
Krishna Institute
|
Consensus Share Price Target
|
754.95 |
782.71 |
- |
3.68 |
buy
|
|
|
|
|
13 Feb 2023
|
Krishna Institute
|
Edelweiss
|
754.95
|
1832.00
|
1457.35
(-48.20%)
|
Target met |
Buy
|
|
|
Acquired assets and gains in the base business drive growth
|
|
12 Feb 2023
|
Krishna Institute
|
Prabhudas Lilladhar
|
754.95
|
1660.00
|
1468.70
(-48.60%)
|
Target met |
Buy
|
|
|
|
|
15 Nov 2022
|
Krishna Institute
|
Axis Direct
|
754.95
|
1740.00
|
1610.30
(-53.12%)
|
Target met |
Buy
|
|
|
the company has a strong RoCE of ~32% and has zero net debt due to its strong operating cash flow generation. Therefore, we recommend BUY with a TP of Rs 1,740/share.
|
|
14 Nov 2022
|
Krishna Institute
|
Prabhudas Lilladhar
|
754.95
|
1660.00
|
1610.30
(-53.12%)
|
Target met |
Buy
|
|
|
|
|
14 Nov 2022
|
Krishna Institute
|
ICICI Securities Limited
|
754.95
|
1691.00
|
1576.35
(-52.11%)
|
Target met |
Buy
|
|
|
Krishna Institute of Medical Sciences’ (KIMS) Q2FY23 performance was slightly below our estimates. Revenues grew 13.8% QoQ to Rs5.6bn (I-Sec: Rs6bn) driven by higher occupancy and addition of beds in existing hospitals.
|
|
12 Nov 2022
|
Krishna Institute
|
Edelweiss
|
754.95
|
1832.00
|
1447.75
(-47.85%)
|
Target met |
Buy
|
|
|
Decent show on normalization of core business
|
|
22 Sep 2022
|
Krishna Institute
|
ICICI Securities Limited
|
754.95
|
1565.00
|
1351.90
(-44.16%)
|
Target met |
Buy
|
|
|
Krishna Institute of Medical Sciences (KIMS) is one of the leading multi-disciplinary integrated private healthcare services provider in Andhra Pradesh and Telangana.
|
|
30 Aug 2022
|
Krishna Institute
|
Prabhudas Lilladhar
|
754.95
|
1550.00
|
1262.65
(-40.21%)
|
Target met |
Buy
|
|
|
|
|
16 Aug 2022
|
Krishna Institute
|
Axis Direct
|
754.95
|
1450.00
|
1226.80
(-38.46%)
|
Target met |
Buy
|
|
|
the company has a strong RoCE ~32% and zero net-debt due to its strong operating cash flow generation. Therefore, we recommend BUY with a TP of Rs 1,450.
|
|
13 Aug 2022
|
Krishna Institute
|
Prabhudas Lilladhar
|
754.95
|
1550.00
|
1226.80
(-38.46%)
|
Target met |
Buy
|
|
|
|